INCY — INCYTE CORP
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 879169 ·
Last close
$124.82
Market Cap
$25.30B
52W High
$132.60
52W Low
$82.52
ADV30
1,417,176
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 1,272,676,000 | 1,168,176,000 | 324,173,000 | 303,330,000 | 7,339,113,000 | 3,461,114,000 | 1,716,266,000 |
| Dec 2025 | 1,506,835,000 | 1,385,735,000 | 383,963,000 | 299,279,000 | 6,957,973,000 | 3,097,817,000 | 1,790,495,000 |
| Sep 2025 | 1,365,980,000 | 1,266,980,000 | 431,296,000 | 424,169,000 | 6,330,356,000 | 2,455,006,000 | 1,679,162,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,979,703,000
Investing CF
$-224,831,000
Financing CF
$275,239,000
CapEx
$-89,237,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$7.85
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$1,102,704,000
Inventory
$112,542,000
Receivables
$1,125,203,000
ST Investments
$553,365,000
EBIT TTM
$1,969,688,000
Pretax Income TTM
$1,967,363,000
Interest Exp TTM
$2,325,000
Analysts
23
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,819,530,240
EBITDA
$1,942,312,960
Free Cash Flow
$1,180,664,576
Enterprise Value
$20,124,221,440
Total Cash
$4,535,739,904
Total Debt
$38,267,000
Shares Out
202,697,746
Trailing EPS
$7.85
Book Value
$31.57
ROE
30.7%
ROA
16.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,141,242,000 | 1,342,790,000 | 1,286,650,000 | 6,957,973,000 | 1,790,495,000 | 5,167,478,000 | 1,413,498,000 |
| Dec 2024 | 4,241,217,000 | 101,294,000 | 32,615,000 | 5,444,322,000 | 1,996,694,000 | 3,447,628,000 | 335,337,000 |
| Dec 2023 | 3,695,649,000 | 655,358,000 | 597,599,000 | 6,782,107,000 | 1,592,270,000 | 5,189,837,000 | 496,487,000 |
| Dec 2022 | 3,394,635,000 | 591,626,000 | 340,660,000 | 5,840,984,000 | 1,470,865,000 | 4,370,119,000 | 969,941,000 |
TTM Snapshot
Revenues TTM
$3,933,097,000
NetIncome TTM
$548,703,000
OpCashFlow TTM
$0
Assets (Latest)
$6,957,973,000
Forward EPS
$8.89
Max Pain — expiry 2026-12-18
max pain strike: $110.00 · spot: $124.82 · call oi: 2,315 · put oi: 10,840
Expected Move to 2026-12-18:
±$20.55
(16.46%) —
implied range
$104.27 –
$145.37
· ATM straddle on $125.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MEDP | Medpace Holdings, Inc. | $17.19B | $615.94 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $41.68B | $529.06 | — |
| IQV | IQVIA HOLDINGS INC. | $44.60B | $270.97 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $14.19B | $294.59 | — |
| ICLR | ICON PLC | $13.55B | $175.57 | — |
News headlines (Yahoo Finance, 1h cache)
Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment
2026-09-28 12:38 · Yahoo
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill
2026-09-25 18:43 · Yahoo
Incyte (INCY) Heads To EADV With New Skin Disease Trial Data
2026-09-24 01:15 · Yahoo
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
2026-09-23 04:53 · Yahoo
Incyte's Colorectal Cancer Program Remains Risky, Long-Term, RBC Says
2026-09-22 15:45 · Yahoo
FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week
2026-09-21 11:06 · Yahoo
Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
2026-09-20 20:00 · Yahoo
Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target
2026-09-20 02:02 · Yahoo
MIRM, INCY Stocks In Focus — Will A September 26 FDA Ruling Reward This Week’s Gains?
2026-09-17 22:44 · Yahoo
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
2026-09-25 23:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.